
#369 - Philip Kantoff, MD, CEO & Co-Founder at Convergent Therapeutics
Episode Details:
Our Guest: Philip Kantoff, MD, CEO & Co-Founder at Convergent Therapeutics
What you'll get out of this episode:
- Kantoff’s background
- Overview of Convergent Therapeutics
- What are the current treatments for prostate cancer and why does it remain an unmet need?
- Can you tell us more about radiopharmaceutical?
- Status of your pipeline
- What’s next?
Watch
Listen